Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From ValiRx Plc
Harbinger Health CEO Stephen Hahn On Early Cancer Detection To ‘Move The Needle’ On Survival
Medtech Insight spoke with Stephen Hahn, ex-FDA commissioner and CEO of Harbinger Health, who attended SXSW, about the firm’s blood-based cancer test in development.
Deal Watch: Merck Looks To Technology Platform Partners For Cytokine Agonist Discovery, Drug Delivery
Plus deals involving Moderna/Metagenomi, Agomab/Origo, Selecta/Ginkgo, Teva/MODAG, Boehringer Ingelheim/Thoeris and X-Chem/ComInnex/Glamorous AI.
Pipeline Watch: Topline Readouts With Keytruda, Cosentyx And Zepsyre
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Pipeline Watch: Phase III Trials In Prostate Cancer, Diffuse Large B-cell Lymphoma
Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.
- In Vitro Diagnostics
Drug Discovery Tools
- Drug Discovery Tools
- Other Names / Subsidiaries
- ValiMedix Limited, ValiRx Bioinnovation Limited, ValiRx Finland OY and ValiPharma Limited.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.